Tae-Wook Chun, Ph.D.

Tae-Wook Chun, Ph.D

Chief, HIV Immunovirology Section

Major Areas of Research

  • Persistence of viral reservoirs in HIV-infected individuals receiving antiretroviral therapy.
  • Viral dynamics and immunologic control of HIV replication in infected individuals.
  • Development of therapeutic strategies aimed at achieving sustained virologic control in HIV-infected individuals in the absence of antiretroviral therapy.

Program Description

Our research program focuses on 1) delineating the role of viral reservoirs in the pathogenesis of HIV disease; 2) examining host and viral factors that contribute to the maintenance of HIV reservoirs; and 3) developing therapeutic strategies aimed at achieving durable virologic control in infected individuals in the absence of antiretroviral therapy. Our research program utilizes Bench-to-Bedside approaches. We conduct comprehensive genetic, immunologic, and virologic analyses of CD4+ and CD8+ T cells in diverse cohorts of HIV-infected individuals in order to address fundamental pathogenic questions, such as elucidating mechanisms of viral persistence, the role of the host immunity in containment of viral replication and evaluating promising novel therapeutic agents in both ex vivo and in vivo settings. Based on findings from bench research, we also conduct phase I clinical trials in close collaboration with the NIAID HIV clinic, with the ultimate goal of developing safe, effective, and scalable therapeutic strategies that would allow HIV-infected individuals to control viral replication in the absence of daily antiretroviral drugs.

Biography

Dr. Chun received his Ph.D. from the Biochemistry, Cellular, and Molecular Biology Graduate Program from the Johns Hopkins University School of Medicine where he discovered and characterized latently infected, resting CD4+ T cells in HIV-infected individuals. He began his postdoctoral work in the Laboratory of Immunoregulation at NIAID as a research fellow in 1997. Subsequently, Dr. Chun was appointed to the position of staff scientist in 2001. Dr. Chun was selected as one of the Earl Stadtman Investigators and received a tenure track investigator position in the LIR in June 2016.

Research Group

Members of the HIV Immunovirology Section Research Group

  • Jana Blazkova, Ph.D., staff scientist
  • Erin D. Huiting, special volunteer
  • J. Shawn Justement, senior research assistant
  • Rachel F. Schneck, postbaccalaureate fellow, Intramural Research Training Awards Program
  • Victoria Shi, M.S., biologist
  • Emily J. Whitehead, postbaccalaureate fellow, Intramural Research Training Awards Program

Selected Publications

Blazkova J, Refsland EW, Clarridge KE, Shi V, Justement JS, Huiting ED, Gittens KR, Chen X, Schmidt SD, Liu C, Doria-Rose N, Mascola JR, Heredia A, Moir S, Chun TW. Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals. J Clin Invest. 2019 Oct 7. pii: 125955.

Sneller MC, Clarridge KE, Seamon C, Shi V, Zorawski MD, Justement JS, Blazkova J, Huiting ED, Proschan MA, Mora JR, Shetzline M, Moir S, Lane HC, Chun TW, Fauci AS. An open-label phase 1 clinical trial of the anti-a4b7 monoclonal antibody vedolizumab in HIV-infected individualsSci Transl Med. 2019 Sep 11;11(509). pii: eaax3447.

Huiting ED, Gittens K, Justement JS, Shi V, Blazkova J, Benko E, Kovacs C, Wender PA, Moir S, Sneller MC, Fauci AS, Chun TW. Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of InfectionJ Infect Dis. 2019 Jun 19;220(2):270-274.

Wang CY, Wong WW, Tsai HC, Chen YH, Kuo BS, Lynn S, Blazkova J, Clarridge KE, Su HW, Lin CY, Tseng FC, Lai A, Yang FH, Lin CH, Tseng W, Lin HY, Finstad CL, Wong-Staal F, Hanson CV, Chun TW*, Liao MJ*. Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment InterruptionN Engl J Med. 2019 Apr 18;380(16):1535-1545.

Clarridge KE, Blazkova J, Einkauf K, Petrone ME, Refsland EW, Sneller MC, Justement JS, Shi V, Huiting ED, Seamon CA, Lee GQ, Yu XG, Moir S, Sneller MC, Lichterfeld M, Chun TW. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individualsPLoS Pathog. 2018 Jan 11;14(1):e1006792.

Visit PubMed for a complete publication listing.

Content last reviewed on